CervoMed Inc. (CRVO)
Last Price$10.7(25.1%)
Market Cap$93.2M
CRVO Rating
CRVO Quality rating performance
CRVO Intrinsic Value
Key Highlights:
As of Mar 24, 2025 CRVO Relative Value is $22.2, which is undervalued by 107.0%, compared to current share price of $10.7.
As of Mar 24, 2025 CRVO DCF Value is $7.2, which is overvalued by 32.7%, compared to current share price of $10.7.
CRVO Share Price History
1W 18.3%
1M 378.1%
6M (29.5%)
YTD 33.9%
1Y (49.2%)
3Y (49.0%)
5Y (52.4%)
10Y (100.0%)
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
CRVO Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$93.2M
$54.3M
$5,636.2K
($19.8M)
Shares Outstanding
8,703K
Employees
N/A
Growth (CAGR)
N/A
23.6%
(61.91%)
14.9%
12.5%
127.35%
Profitability
50.1%
(323.4%)
(289.0%)
(350.8%)
(350.8%)
93.4%
Intrinsic Value
$14.8 (38.5% undervalued)
$7.2
$22.5
($73.6)
($141.7)
(100.0%)
615.6%
Valuation (LTM)
Return on Capital
Financial Health
($38.9M)
2.0x
Dividends
Earnings
Aug 07, 2025
BEAT by 6.2%
MISS by 25.5%
5 Beat & 5 Miss
CRVO Stock Financials
CRVO Income Statement Metrics
Annual
Quarterly
LTM
CRVO Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
($7,449.8K) -50.2% YoY
Capital Expenditure (CAPEX)
($3.0) N/A YoY
Free Cash Flow (FCF)
($7,449.8K) -50.2% YoY
CRVO Income Statement Overview
Annual
Quarterly
LTM
Dec'14
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
$7,144.9K 0.0% YoY
Cost of revenue
$8,438.5K 531.4% YoY
Operating
expenses
$15.0M 330.4% YoY
Other: $2,171.9K
CRVO Balance Sheet Overview
Annual
Quarterly
LTM
Dec'14
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Assets
Liabilities
Total assets
$9,972.5K
Current assets ($9,964.8K, 99.9% of total)
$7,792.8K (78.1%)
$915.4K (9.2%)
Other current assets
$1,256.5K (12.6%)
Non-current assets ($7,770.0, 0.1% of total)
$0.0 (0.0%)
$0.0 (0.0%)
$0.0 (0.0%)
Other non-current assets
$7,770.0 (0.1%)
Financial position
($7,792.8K)
Cash & Short-term
Investments
Total Debt
CRVO Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
CRVO Earnings Surprises
Crunching data... Almost there!
CRVO Dividends
CRVO Dividend Yield
Crunching data... Almost there!
CRVO Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with CRVO
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$93.2M | 6.2 | $14.8 38.5% undervalued | (49.2%) | $5,636.2K | ($19.8M) | 3.9% | (350.8%) | 50.1% | 48,286.4% | 0.0% | |
$131.8B | 5.8 | $186.0 63.7% overvalued | 23.0% | $11.0B | ($790.3M) | 11.5% | (7.2%) | 86.1% | (15.0%) | 10.7% | |
$71.1B | 6.4 | $1,034.1 56.4% undervalued | (31.1%) | $14.2B | $3,597.2M | 8.3% | 25.3% | 84.5% | 25.7% | 5.7% | |
$43.1B | 6.3 | $161.4 73.4% overvalued | 52.6% | $3,154.8M | ($58.8M) | 157.1% | (1.9%) | 74.8% | 67.0% | 0.7% | |
$37.4B | 5.2 | $92.7 68.1% overvalued | 91.2% | $2,248.2M | ($42.6M) | 23.0% | (1.9%) | 85.6% | (7.2%) | 1,931.9% | |
$24.2B | 6.0 | $193.7 92.5% undervalued | 8.2% | €2,751.1M | (€229.8M) | (28.0%) | (8.4%) | 80.3% | (37.8%) | 1.3% | |
$15.1B | 5.5 | $68.9 104.3% undervalued | 14.9% | $2,263.9M | $2,769.0M | (3.8%) | 122.3% | 73.9% | 14.5% | 73.6% | |
$15.0B | 6.0 | $0.6 97.2% overvalued | 530.8% | $0.0 | ($142.1M) | N/A | N/A | N/A | (3,335.4%) | 1.9% | |
$14.3B | 7.8 | $542.3 69.6% undervalued | 31.0% | $2,877.4M | $1,080.6M | 23.6% | 37.6% | 89.2% | 65.4% | 4.7% | |
$13.7B | 6.8 | $50.8 29.4% overvalued | (16.8%) | $2,850.5M | $475.4M | 17.8% | 16.7% | 78.6% | 11.0% | 10.7% | |
$1,846.9M | 5.5 | $2,609.6 1,051.1% undervalued | 39.9% | $3,316.8M | ($1,041.0M) | 50.5% | (31.4%) | 83.7% | (43.2%) | 32.1% |
FAQ
What is CervoMed Inc. (CRVO) stock rating?
As of today, CervoMed Inc. has a stock rating of 6 (out of 10), which is considered Good.
is CervoMed Inc. (CRVO) a good stock to buy?
As of today, CervoMed Inc. has a Good stock rating, which is 38.5% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.